MannKind Corp. Company Profile (NASDAQ:MNKD)

About MannKind Corp.

MannKind Corp. logoMannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: MNKD
  • CUSIP: 56400P20
Key Metrics:
  • Previous Close: $0.87
  • 50 Day Moving Average: $1.01
  • 200 Day Moving Average: $1.20
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.21
  • P/E Growth: -0.16
  • Market Cap: $415.90M
  • Outstanding Shares: 478,048,000
  • Beta: 1.65
Additional Links:
Companies Related to MannKind Corp.:

Analyst Ratings

Consensus Ratings for MannKind Corp. (NASDAQ:MNKD) (?)
Ratings Breakdown: 4 Sell Ratings, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Hold (Score: 1.71)
Consensus Price Target: $2.84 (226.67% upside)

Analysts' Ratings History for MannKind Corp. (NASDAQ:MNKD)
DateFirmActionRatingPrice TargetDetails
8/21/2016Piper Jaffray Cos.Set Price TargetSell$0.10View Rating Details
8/8/2016JPMorgan Chase & Co.Reiterated RatingSellView Rating Details
6/1/2016Royal Bank Of CanadaLower Price TargetUnderperform$1.00 -> $0.15View Rating Details
4/28/2016JMP SecuritiesReiterated RatingHoldView Rating Details
4/1/2016Goldman Sachs Group Inc.Reiterated RatingSellView Rating Details
1/27/2016S&P Equity ResearchLower Price Target$1.12 -> $0.96View Rating Details
1/6/2016Griffin SecuritiesUpgradeNeutral -> Buy$4.00View Rating Details
11/14/2015Jefferies GroupReiterated RatingBuy$9.00View Rating Details
5/11/2015MLV & Co.Lower Price TargetHold$7.00 -> $4.00View Rating Details
(Data available from 8/25/2014 forward)


Earnings History for MannKind Corp. (NASDAQ:MNKD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q2($0.06)($0.07)$0.03 millionViewN/AView Earnings Details
5/9/2016Q116($0.04)($0.06)ViewN/AView Earnings Details
3/14/2016Q4($0.05)($0.66)$0.35 millionViewN/AView Earnings Details
11/9/2015Q315($0.07)($0.08)ViewN/AView Earnings Details
8/10/2015Q215($0.08)($0.07)$0.53 millionViewListenView Earnings Details
5/7/2015Q115($0.08)($0.08)ViewListenView Earnings Details
2/24/2015Q414($0.09)($0.09)$3.13 millionViewListenView Earnings Details
11/3/2014Q314$0.04($0.09)$66.60 millionViewListenView Earnings Details
8/11/2014Q214($0.12)($0.19)ViewListenView Earnings Details
5/12/2014Q114($0.13)($0.14)ViewListenView Earnings Details
2/18/2014Q4($0.14)($0.16)$0.43 millionViewListenView Earnings Details
11/4/2013Q313($0.14)($0.17)ViewListenView Earnings Details
8/9/2013Q2 2013($0.14)($0.16)ViewN/AView Earnings Details
5/9/2013Q1 2013($0.15)($0.15)ViewListenView Earnings Details
2/11/2013Q4 2012($0.19)($0.23)ViewListenView Earnings Details
11/1/2012Q312($0.24)($0.22)ViewN/AView Earnings Details
8/7/2012($0.24)($0.23)ViewN/AView Earnings Details
5/9/2012($0.23)($0.27)ViewN/AView Earnings Details
2/22/2012($0.32)($0.30)ViewN/AView Earnings Details
11/3/2011($0.32)($0.31)ViewN/AView Earnings Details
8/4/2011($0.30)($0.37)ViewN/AView Earnings Details
5/9/2011($0.29)($0.34)ViewN/AView Earnings Details
2/10/2011($0.40)($0.33)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for MannKind Corp. (NASDAQ:MNKD)
Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $-0.14 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.03)($0.03)($0.03)
Q2 20161($0.03)($0.03)($0.03)
Q3 20161($0.03)($0.03)($0.03)
Q4 20161($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)


Dividend History for MannKind Corp. (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for MannKind Corp. (NASDAQ:MNKD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/24/2016Michael CastagnaInsiderBuy15,000$0.87$13,050.00View SEC Filing  
8/23/2016Michael CastagnaInsiderBuy25,000$0.94$23,500.00View SEC Filing  
8/15/2016Matthew J PfefferCEOBuy25,000$0.99$24,750.00View SEC Filing  
8/12/2016Michael CastagnaInsiderBuy25,000$1.00$25,000.00View SEC Filing  
5/17/2016Michael CastagnaInsiderBuy50,000$0.93$46,500.00View SEC Filing  
4/24/2015Hakan EdstromCEOSell73,460$4.83$354,811.80View SEC Filing  
3/27/2015Hakan EdstromCEOSell73,460$5.21$382,726.60View SEC Filing  
2/10/2015Hakan EdstromCEOSell73,460$7.75$569,315.00View SEC Filing  
2/5/2015David ThomsonVPSell80,000$7.00$560,000.00View SEC Filing  
1/5/2015Diane PalumboVPSell188,999$5.95$1,124,544.05View SEC Filing  
11/24/2014David ThomsonVPSell118,114$6.14$725,219.96View SEC Filing  
10/3/2014Juergen MartensVPSell63,800$5.48$349,624.00View SEC Filing  
8/27/2014Juergen MartensVPSell417$7.60$3,169.20View SEC Filing  
8/7/2014David ThomsonVPSell30,000$8.16$244,800.00View SEC Filing  
7/21/2014Juergen MartensVPSell26,458$9.65$255,319.70View SEC Filing  
7/15/2014Diane PalumboVPSell17,901$10.01$179,189.01View SEC Filing  
7/1/2014Matthew J PfefferCFOSell20,000$10.44$208,800.00View SEC Filing  
6/30/2014Hakan EdstromCOOBuy1,692$4.42$7,478.64View SEC Filing  
6/27/2014Juergen MartensVPSell25,417$10.53$267,641.01View SEC Filing  
6/26/2014David ThomsonVPSell30,000$10.51$315,300.00View SEC Filing  
6/20/2014Juergen MartensVPSell1,458$10.34$15,075.72View SEC Filing  
6/16/2014Diane PalumboVPSell17,902$10.59$189,582.18View SEC Filing  
6/5/2014Juergen MartensVPSell120,000$11.00$1,320,000.00View SEC Filing  
6/4/2014David ThomsonVPSell133,000$9.95$1,323,350.00View SEC Filing  
6/3/2014Diane PalumboVPSell52,957$9.50$503,091.50View SEC Filing  
5/23/2014Juergen MartensVPSell25,000$7.65$191,250.00View SEC Filing  
5/19/2014Juergen MartensVPSell76,899$7.50$576,742.50View SEC Filing  
5/15/2014Diane PalumboVPSell18,176$7.06$128,322.56View SEC Filing  
1/24/2014Juergen MartensVPSell50,000$5.56$278,000.00View SEC Filing  
12/31/2013Hakan EdstromCOOBuy1,589$4.53$7,198.17View SEC Filing  
12/20/2013Juergen MartensVPSell32,054$5.00$160,270.00View SEC Filing  
12/11/2013David ThomsonVPSell150,000$5.00$750,000.00View SEC Filing  
11/29/2013Juergen MartensVPSell48,057$5.01$240,765.57View SEC Filing  
11/15/2013Diane PalumboVPSell25,000$5.02$125,500.00View SEC Filing  
8/28/2013David ThomsonVPSell19,204$5.78$110,999.12View SEC Filing  
8/26/2013Juergen MartensVPSell20,000$5.52$110,400.00View SEC Filing  
8/1/2013Matthew J PfefferCFOSell10,000$8.00$80,000.00View SEC Filing  
7/2/2013Matthew J PfefferCFOSell10,000$7.00$70,000.00View SEC Filing  
6/30/2013Diane PalumboVPBuy1,610$1.96$3,155.60View SEC Filing  
6/30/2013Matthew J PfefferCFOBuy7,448$1.96$14,598.08View SEC Filing  
6/3/2013Diane PalumboVPSell66,849$7.50$501,367.50View SEC Filing  
5/16/2013Diane PalumboVPSell26,829$5.25$140,852.25View SEC Filing  
5/15/2013Matthew J PfefferCFOSell10,000$5.00$50,000.00View SEC Filing  
12/31/2012Matthew J PfefferCFOBuy1,056$1.95$2,059.20View SEC Filing  
12/21/2012Alfred E MannMajor ShareholderBuy40,000,000$2.59$103,600,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for MannKind Corp. (NASDAQ:MNKD)
DateHeadline logo3 Stocks We Wouldn't Touch With a 10-Foot Pole (NASDAQ:MNKD) - August 22 at 2:28 PM logoPiper Jaffray Provides 2H16 Outlook for MannKind Corporation (MNKD) - Smarter Analyst (NASDAQ:MNKD) - August 20 at 10:18 AM logoMannKind : MNKD) Relaunches Groundbreaking Inhalable Insulin Afrezza®, Promotes New Copay System (NASDAQ:MNKD) - August 19 at 6:08 PM
News IconMannKind Corp. (MNKD) Relaunches Groundbreaking Inhalable Insulin Afrezza®, Promotes New Copay System (NASDAQ:MNKD) - August 19 at 6:08 PM logoPiper Jaffray Provides 2H16 Outlook for MannKind Corporation (MNKD) (NASDAQ:MNKD) - August 19 at 6:08 PM logoMANNKIND CORP Financials (NASDAQ:MNKD) - August 18 at 6:22 PM
News IconHealthcare Stocks Tossing Up on Investment Valuation: MannKind Corp. (NASDAQ:MNKD), Johnson & Johnson ... - Street Wise Report (press release) (blog) (NASDAQ:MNKD) - August 17 at 6:26 PM logoMannKind Corporation (MNKD) Skeptics Still Skeptical After Afrezza Relaunch - (NASDAQ:MNKD) - August 17 at 9:19 AM logoMNKD: Insiders vs. Shorts (NASDAQ:MNKD) - August 16 at 6:21 PM logoMannKind Corporation (MNKD) Skeptics Still Skeptical After Afrezza Relaunch (NASDAQ:MNKD) - August 16 at 9:19 AM
News IconMannKind (MNKD) Stock: Long Road Ahead, but the Fights Not Over! (NASDAQ:MNKD) - August 15 at 6:25 PM logoPiper Jaffray Remains Bearish on MannKind Corporation (MNKD) Amid 2Q Update; Sees 90% Downside for the Stock (NASDAQ:MNKD) - August 10 at 6:38 PM logoMANNKIND CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:MNKD) - August 10 at 6:38 PM logoMannkind Corporation: More Losses (NASDAQ:MNKD) - August 10 at 9:17 AM logoMANNKIND CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:MNKD) - August 10 at 9:17 AM logoThe 6 Most Shorted Nasdaq Stocks: Intel Slips Down the List (NASDAQ:MNKD) - August 10 at 9:17 AM logoShort Sellers Run for Cover From Major Biotechs (NASDAQ:MNKD) - August 10 at 9:17 AM
News Icon2 Biotech Stocks News And Price Trends: MannKind Corp. (NASDAQ:MNKD), Sarepta Therapeutics, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:MNKD) - August 9 at 6:29 PM
News IconMannKind Barely Misses Estimates (NASDAQ:MNKD) - August 9 at 9:23 AM logoEARNINGS SUMMARY: Details of MannKind Corp. Q2 Earnings Report (NASDAQ:MNKD) - August 9 at 9:23 AM logoMannKind Corporation: MannKind Corporation Reports 2016 Second Quarter Financial Results (NASDAQ:MNKD) - August 9 at 9:23 AM logoCompany Update (NASDAQ:MNKD): MannKind Corporation Reports 2016 Second Quarter Financial Results (NASDAQ:MNKD) - August 9 at 9:23 AM logoMannKind reports 2Q loss (NASDAQ:MNKD) - August 9 at 9:23 AM
News IconHC Stocks Movements: MannKind Corporation (NASDAQ:MNKD), Advaxis, Inc. (NASDAQ:ADXS) - share market updates (press release) (NASDAQ:MNKD) - August 8 at 6:27 PM logoMannKind Corporation Reports 2016 Second Quarter Financial Results (NASDAQ:MNKD) - August 8 at 6:26 PM logoQ2 2016 MannKind Corp Earnings Release - After Market Close (NASDAQ:MNKD) - August 8 at 10:54 AM logoWhat to Expect from MannKind's (MNKD) Q2 Earnings Report (NASDAQ:MNKD) - August 5 at 6:26 PM logoQuestions Mount As MannKind Corporation Slides Another 15% in July (NASDAQ:MNKD) - August 5 at 1:54 PM
News IconActive biotech company shares in the news: MannKind Corp. (NASDAQ:MNKD), Intrexon Corporation (NYSE:XON) - The Voice Registrar (NASDAQ:MNKD) - August 4 at 6:35 PM
News IconMannKind Corporation (MNKD) Stock: All Aboard | Destination Gains! - CNA Finance (press release) (NASDAQ:MNKD) - August 4 at 6:35 PM logoMannKind Corp. (NASDAQ:MNKD): Updated Analyst Ratings ... - Review Fortune (NASDAQ:MNKD) - August 4 at 6:35 PM logo3 Notable Runners: Lions Gate Entertainment Corp. (LGF), MannKind Corp. (MNKD), Realty Income Corporation (O) - iStreetWire (NASDAQ:MNKD) - August 3 at 9:33 AM logoMannKind: Longs Celebrating And Shorts Closing Their Positions (NASDAQ:MNKD) - August 2 at 6:32 PM
News IconNews review of 2 biotech stocks: MannKind Corp. (NASDAQ:MNKD), Nektar Therapeutics (NASDAQ:NKTR) - The Voice Registrar (NASDAQ:MNKD) - August 2 at 11:03 AM logoMannKind (MNKD) Assumes Responsibility for Distribution of Afrezza; Launches Patient Reimbursement Programs (NASDAQ:MNKD) - August 1 at 6:01 PM logoMannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 201 (NASDAQ:MNKD) - August 1 at 6:01 PM logoMannKind Corporation to Hold 2016 Second Quarter Financial Results Conference Call on August 8, 2016 (NASDAQ:MNKD) - August 1 at 6:00 PM logoMajor Biotechs See Increased Short Interest Bets (NASDAQ:MNKD) - July 27 at 7:50 AM logoEye Catching Stocks: MannKind Corp. (MNKD), Bed Bath & Beyond Inc. (BBBY), Progressive Corp. (PGR) - iStreetWire (NASDAQ:MNKD) - July 26 at 9:27 AM logoWhich way MannKind Corp. (NASDAQ:MNKD) insiders are heading ... - Review Fortune (NASDAQ:MNKD) - July 25 at 6:21 PM logoMannkind - With Afreza Prescriptions Bottoming Out, Catalysts Arrive In August To Spur Sales (NASDAQ:MNKD) - July 25 at 10:44 AM
News IconMannKind Corporation (MNKD) Stock: One Thing Could Send It Over The Top! (NASDAQ:MNKD) - July 22 at 9:10 AM
News IconMannKind Corporation (MNKD) Stock: One Thing Could Send It Over The Top! - CNA Finance (press release) (NASDAQ:MNKD) - July 21 at 6:28 PM
News IconIntraday Active Biotech Stocks News: MannKind Corp. (NASDAQ:MNKD), Juno Therapeutics Inc. (NASDAQ:JUNO) - The Voice Registrar (NASDAQ:MNKD) - July 21 at 9:05 AM
News IconHot Biotech Stocks Recap: Mast Therapeutics, Inc. (NYSEMKT:MSTX), MannKind Corp. (NASDAQ:MNKD) - The Voice Registrar (NASDAQ:MNKD) - July 20 at 9:09 AM
News Icon2 Biotech Stocks News And Price Trends: MannKind Corp. (NASDAQ:MNKD), Relypsa, Inc. (NASDAQ:RLYP) - The Voice Registrar (NASDAQ:MNKD) - July 19 at 6:21 PM
News IconHC Stocks Newsbeat: CVS Health Corp (NYSE:CVS) MannKind Corporation (NASDAQ:MNKD) - share market updates (press release) (NASDAQ:MNKD) - July 18 at 6:23 PM
News IconAnalyst Opinion of: MannKind Corp. (NASDAQ:MNKD) - News Oracle (NASDAQ:MNKD) - July 18 at 6:23 PM
News IconHC Stocks Growth: MannKind Corporation (NASDAQ:MNKD), Boston Scientific Corporation (NYSE:BSX) - share market updates (press release) (NASDAQ:MNKD) - July 15 at 5:17 PM logoMannKind Corporation (MNKD) Drops 5.31% on July 13 - (NASDAQ:MNKD) - July 15 at 10:39 AM


MannKind Corp. (NASDAQ:MNKD) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff